The dark side of browning
Received date: 02 Apr 2017
Accepted date: 31 May 2017
Published date: 22 Mar 2018
Copyright
The induction of brown-like adipocyte development in white adipose tissue (WAT) confers numerous metabolic benefits by decreasing adiposity and increasing energy expenditure. Therefore, WAT browning has gained considerable attention for its potential to reverse obesity and its associated co-morbidities. However, this perspective has been tainted by recent studies identifying the detrimental effects of inducing WAT browning. This review aims to highlight the adverse outcomes of both overactive and underactive browning activity, the harmful side effects of browning agents, as well as the molecular brake-switch system that has been proposed to regulate this process. Developing novel strategies that both sustain the metabolic improvements of WAT browning and attenuate the related adverse side effects is therefore essential for unlocking the therapeutic potential of browning agents in the treatment of metabolic diseases.
Key words: adipocyte; browning; beige adipocyte; thermogenesis; obesity; diabetes
Kirstin A. Tamucci , Maria Namwanje , Lihong Fan , Li Qiang . The dark side of browning[J]. Protein & Cell, 2018 , 9(2) : 152 -163 . DOI: 10.1007/s13238-017-0434-2
1 |
Ab<?Pub Caret?>bas A, Blandon J, Rude J
|
2 |
Aherne W, Hull D (1966) Brown adipose tissue and heat production in the newborn infant. J Pathol Bacteriol 91:223–234.
|
3 |
Alvarez-Dominguez JR, Bai Z, Xu D
|
4 |
Arch JRS (2002) beta(3)-Adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol 440:99–107
|
5 |
Argilés JM, Busquets S, Stemmler B, López-Soriano FJ (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14:754–762.
|
6 |
Barbatelli G, Murano I, Madsen L
|
7 |
Barzilai N, Huffman DM, Muzumdar RH, Bartke A (2012) The critical role of metabolic pathways in aging. Diabetes 61:1315–1322.
|
8 |
Bauer DC, Ettinger B, Nevitt MC
|
9 |
Boon MR, van der Horst G, van der Pluijm G
|
10 |
Boon MR, van den Berg SAA, Wang Y
|
11 |
Buijs JT, Henriquez NV, van Overveld PGM
|
12 |
Bundgaard H, Axelsson A, Hartvig Thomsen J
|
13 |
Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84:277–359
|
14 |
Carreira AC, Lojudice FH, Halcsik E
|
15 |
Cederberg A, Gronning LM, Ahren B
|
16 |
Chau MDL, Gao J, Yang Q
|
17 |
Chondronikola M, Volpi E, Børsheim E
|
18 |
Chondronikola M, Volpi E, Børsheim E
|
19 |
Cohen P, Levy JD, Zhang Y
|
20 |
Coskun T, Bina HA, Schneider MA
|
21 |
Cypess AM, Lehman S, Williams G
|
22 |
Cypess AM, Weiner LS, Roberts-Toler C
|
23 |
Das SK, Eder S, Schauer S
|
24 |
Dodd GT, Decherf S, Loh K
|
25 |
Dutchak PA, Katafuchi T, Bookout AL
|
26 |
Elias I, Franckhauser S, Ferré T
|
27 |
Farmer SR (2006) Transcriptional control of adipocyte formation. Cell Metab 4:263–273.
|
28 |
Fearon KCH, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16:153–166.
|
29 |
Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10:90–99.
|
30 |
Ferrannini G, Namwanje M, Fang B
|
31 |
Ferrara N, Adamis AP (2016) Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov 15:385–403.
|
32 |
Fischer K, Ruiz HH, Jhun K
|
33 |
Fisher FM, Kleiner S, Douris N
|
34 |
Frontini A, Vitali A, Perugini J
|
35 |
Gaich G, Chien JY, Fu H
|
36 |
Gerhart-Hines Z, Feng D, Emmett MJ
|
37 |
Gesta S, Tseng YH, Kahn CR (2007) Developmental origin of fat: tracking obesity to its source. Cell 131:242–256.
|
38 |
Grefhorst A, van den Beukel JC, van Houten ELA
|
39 |
Guerra C, Koza RA, Yamashita H
|
40 |
Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367–377.
|
41 |
Guntur AR, Doucette CR, Rosen CJ (2015) PTHrp comes full circle in cancer biology. Bonekey Rep 4:621.
|
42 |
Gupta RK, Arany Z, Seale P
|
43 |
Hankir MK, Cowley MA, Fenske WK (2016) A BAT-centric approach to the treatment of diabetes: turn on the brain. Cell Metab 24:31–40.
|
44 |
Himms-Hagen J, Cui J, Danforth EJ
|
45 |
Himms-Hagen J, Melnyk A, Zingaretti MC
|
46 |
Inagaki T, Dutchak P, Zhao G
|
47 |
Inagaki T, Lin VY, Goetz R
|
48 |
Jeschke MG (2009) The hepatic response to thermal injury: is the liver important for postburn outcomes? Mol Med 15:337–351.
|
49 |
Jeschke MG, Gauglitz GG, Finnerty CC
|
50 |
Kernan WN, Viscoli CM, Furie KL
|
51 |
Kharitonenkov A, Shiyanova TL, Koester A
|
52 |
Kharitonenkov A, Wroblewski VJ, Koester A
|
53 |
Kim JK, Kim H-J, Park S-Y
|
54 |
Kim J-Y, van de Wall E, Laplante M
|
55 |
Kim H-J, Cho H, Alexander R
|
56 |
Kir S, White JP, Kleiner S
|
57 |
Kir S, Komaba H, Garcia AP
|
58 |
Knowler WC, Hamman RF, Edelstein SL
|
59 |
Kong X, Banks A, Liu T
|
60 |
Kopecky J, Clarke G, Enerback S
|
61 |
Kulp GA, Herndon DN, Lee JO
|
62 |
Lee Y-H, Petkova AP, Mottillo EP, Granneman JG (2012) In vivo identification of bipotential adipocyte progenitors recruited by β3-adrenoceptor activation and high-fat feeding. Cell Metab 15:480–491.
|
63 |
Li D, Zhang F, Zhang X
|
64 |
Lim YC, Chia SY, Jin S
|
65 |
Lin JZ, Martagón AJ, Cimini SL
|
66 |
Liu T, Kong D, Shah BP
|
67 |
Long JZ, Svensson KJ, Tsai L
|
68 |
Lu X, Ji Y, Zhang L
|
69 |
Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175–184.
|
70 |
Ma X, Xu L, Gavrilova O, Mueller E (2014) Role of forkhead box protein A3 in age-associated metabolic decline. Proc Natl Acad Sci USA 111:14289–14294.
|
71 |
Ma X, Xu L, Mueller E (2015) Calorie hoarding and thrifting: Foxa3 finds a way. Adipocyte 4:325–328.
|
72 |
Maioli E, Fortino V, Torricelli C
|
73 |
McDonald ME, Li C, Bian H
|
74 |
Medina-Gomez G, Calvo RM, Obregon MJ (2008) Thermogenic effect of triiodothyroacetic acid at low doses in rat adipose tissue without adverse side effects in the thyroid axis. Am J Physiol Endocrinol Metab 294:E688–E697.
|
75 |
Moghri J, Akbari Sari A, Yousefi M
|
76 |
Moolman JA (2002) Thyroid hormone and the heart. Cardiovasc J S Afr 13:159–163
|
77 |
Mullur R, Liu Y-Y, Brent GA (2014) Thyroid hormone regulation of metabolism. Physiol Rev 94:355–382.
|
78 |
Murphy E, Williams GR (2004) The thyroid and the skeleton. Clin Endocrinol (Oxf) 61:285–298.
|
79 |
Nedergaard J, Cannon B (2010) The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab 11:268–272.
|
80 |
Nedergaard J, Bengtsson T, Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293:E444–E452
|
81 |
Ng Y, Tan S-X, Chia SY
|
82 |
Nguyen KD, Qiu Y, Cui X
|
83 |
Ohno H, Shinoda K, Spiegelman BM, Kajimura S (2012) PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 15:395–404.
|
84 |
Ortega-Molina A, Efeyan A, Lopez-Guadamillas E
|
85 |
Patsouris D, Qi P, Abdullahi A
|
86 |
Pedroso FE, Spalding PB, Cheung MC (2012) Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia. J Cachexia Sarcopenia Muscle 3 (3):199–211
|
87 |
Petrovic N, Walden TB, Shabalina IG
|
88 |
Petruzzelli M, Schweiger M, Schreiber R
|
89 |
Qiang L, Wang L, Kon N
|
90 |
Qiao L, Yoo HS, Bosco C
|
91 |
Rajakumari S, Wu J, Ishibashi J
|
92 |
Randall SM, Fear MW, Wood FM
|
93 |
Rogers NH, Landa A, Park S, Smith RG (2012) Aging leads to a programmed loss of brown adipocytes in murine subcutaneous white adipose tissue. Aging Cell 11:1074–1083.
|
94 |
Rong JX, Qiu Y, Hansen MK
|
95 |
Rosenwald M, Perdikari A, Rülicke T, Wolfrum C (2013) Bidirectional interconversion of brite and white adipocytes. Nat Cell Biol 15:659–667.
|
96 |
Rothwell NJ, Stock MJ (1979) A role for brown adipose tissue in dietinduced thermogenesis. Nature 281:31–35
|
97 |
Saito M, Okamatsu-Ogura Y, Matsushita M
|
98 |
Sanchez-Gurmaches J, Hung C-M, Sparks CA
|
99 |
Seale P, Kajimura S, Yang W
|
100 |
Seale P, Bjork B, Yang W
|
101 |
Seale P, Conroe HM, Estall J
|
102 |
Sell H, Berger JP, Samson P
|
103 |
Shah P, Mudaliar S (2010) Pioglitazone: side effect and safety profile. Expert Opin Drug Saf 9:347–354.
|
104 |
Shao M, Ishibashi J, Kusminski CM
|
105 |
Sidossis LS, Porter C, Saraf MK
|
106 |
Smith RE, Hock RJ (1963) Brown fat: thermogenic effector of arousal in hibernators. Science 140:199–200
|
107 |
Soccio RE, Chen ER, Lazar MA (2014) Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab 20:573–591.
|
108 |
Stefl B, Janovská A, Hodný Z
|
109 |
Sun K, Wernstedt Asterholm I, Kusminski CM
|
110 |
Sung H-K, Doh K-O, Son JE
|
111 |
Tchkonia T, Morbeck DE, Von Zglinicki T
|
112 |
Tseng YH, Kokkotou E, Schulz TJ
|
113 |
Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880.
|
114 |
van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM
|
115 |
Vegiopoulos A, Müller-Decker K, Strzoda D
|
116 |
Vernochet C, Peres SB, Davis KE
|
117 |
Villanueva CJ, Waki H, Godio C
|
118 |
Villanueva CJ, Vergnes L, Wang J
|
119 |
Virtanen KA, Lidell ME, Orava J
|
120 |
Wada S, Neinast M, Jang C
|
121 |
Wang QA, Tao C, Gupta RK, Scherer PE (2013) Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 19:1338–1344.
|
122 |
Wei W, Dutchak PA, Wang X
|
123 |
Wente W, Efanov AM, Brenner M
|
124 |
Weyer C, Tataranni PA, Snitker S
|
125 |
Wilson-Fritch L, Nicoloro S, Chouinard M
|
126 |
Wu J, Boström P, Sparks LM
|
127 |
Xiu F, Catapano M, Diao L
|
128 |
Xiu F, Diao L, Qi P
|
129 |
Yan M, Audet-Walsh É, Manteghi S
|
130 |
Yoneshiro T, Aita S, Matsushita M
|
131 |
Zechner R, Zimmermann R, Eichmann TO
|
/
〈 | 〉 |